Spyre Therapeutics
SYRE
#5743
Rank
โ‚ฌ0.74 B
Marketcap
12,43ย โ‚ฌ
Share price
-5.36%
Change (1 day)
-58.93%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -โ‚ฌ0.2 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ0.19 Billion62.23%
2023 -โ‚ฌ0.12 Billion51.64%
2022 -โ‚ฌ74.58 Million29.14%
2021 -โ‚ฌ57.75 Million-19.43%
2020 -โ‚ฌ71.68 Million1.43%
2019 -โ‚ฌ70.67 Million76.7%
2018 -โ‚ฌ39.99 Million64.27%
2017 -โ‚ฌ24.35 Million26.34%
2016 -โ‚ฌ19.27 Million93.6%
2015 -โ‚ฌ9.96 Million27.08%
2014 -โ‚ฌ7.84 Million